Tier 2 — strong

The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers

Xin HW, Wu XC, Li Q, Yu AR, Zhong MY, Liu YY
Methods and findings in experimental and clinical pharmacology 2006 28(1):25-29

Bibliography

PubMed
PMID 16541194
Funding
Funding was not established from the accessible source; this is not a declaration of no funding.
Competing interests
A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.

Study snapshot

DesignTwo small healthy-volunteer interaction studies
ModelHuman participants; see population
Sample12 healthy men in two six-person experiments
InterventionCyclosporine with repeated or single-dose berberine
Duration10-day repeated-dose experiment and separate acute comparison
EndpointsPlasma exposure and pharmacokinetics; Drug interaction measurements; Short-term tolerability

What the study showed, in plain terms

Interaction results differed by cyclosporine regimen: exposure increased in one experiment but not the other.

Key findings

  • Interaction results differed by cyclosporine regimen: exposure increased in one experiment but not the other.

What this study can and cannot tell us

Very small groups. The absence of change in one regimen does not negate the transplant-recipient interaction.

Source detail: indexed abstract and bibliographic record; unavailable methods or disclosures are identified rather than assumed.

Citation network

Articles citing this research paper

2 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified